Abstract. The gastric pathogen, helicobacter pylori (H. pylori), has been associated with the progression of gastric cancer. It was previously reported that H. pylori induced urokinase plasminogen activator receptor (uPAR) expression and stimulated cell invasiveness in human gastric cancer AGS cells. However, the precise mechanisms for how H. pylori upregulates uPAR are unclear. This study investigated the underlying signal pathways in H. pylori-induced uPAR in human gastric cancer AGS cells. The intracellular H 2 O 2 content, as determined using H 2 O 2 -sensitive probe 2',7'-dichlorodihydrofluorescein, increased after the H. pylori treatment. N-acetyl cysteine (NAC), an antioxidant, prevented the H. pylori-induced production of H 2 O 2 and uPAR expression. In addition, exogenous H 2 O 2 was found to increase uPAR mRNA expression and its promoter activity. Sitedirected mutagenesis of the potential NF-κB element in the uPAR promoter showed that the redox-sensitive transcription factor NF-κB was essential for H. pylori-induced uPAR expression. The expression of vectors encoding a mutatedtype NF-κB-inducing kinase and I-κB, and a specific inhibitor of NF-κB (BAY11-7082) decreased the H. pyloriinduced uPAR promoter activity. Chromatin immunoprecipitation and the electrophoretic mobility shift assay confirmed that H. pylori increased the DNA binding activity of NF-κB. With the aid of NAC and H 2 O 2 , it was determined that reactive oxygen species (ROS) is an upstream signaling molecule for activating the NF-κB induced by H. pylori. The enhanced AGS cell invasiveness by H. pylori was partially abrogated by an NAC and BAY11-7082 treatment. These results suggest that the ROS and NF-κB signaling pathway is important in H. pylori-induced uPAR expression and the increased cell invasiveness of human gastric cancer AGS cells.
Introduction
Despite the improved prognosis of gastric cancer resulting from the early diagnosis and development of adjuvant therapy, gastric cancer remains the second most common cause of cancer deaths worldwide. Approximately 80% of the gastric cancers in Western countries are at an advanced stage at diagnosis (1) . Chemotherapy does not significantly affect the length or quality of life of advanced gastric cancer patients due to local invasion and metastasis. An understanding of the detailed mechanisms of invasion and metastasis in gastric cancer would be helpful in improving the treatment outcome.
H. pylori is believed to be the major etiological factor in the development of gastric cancer. Large-scale epidemiological studies have confirmed the strong association between H. pylori infection and both cancer and its histological stages (2) . Animal models have also demonstrated the importance of H. pylori in gastric carcinogenesis (3) . Recently, studies have indicated that H. pylori plays an important role, not only in the development of gastric cancer, but also in the process of tissue remodeling, angiogenesis, tumor invasion and metastasis (4) .
Cancer invasion and metastasis are multifactorial processes that require the coordinated action of cell-secreted proteolytic enzymes and their inhibitors (5) . Urokinase-type plasminogen activator (uPA), its inhibitors, and uPA receptor (uPAR) form a complex proteolytic system that has been implicated in cancer invasion and metastasis. uPA, a serine protease, has the ability to convert plasminogen to active plasmin (6) . Furthermore, the uPA-uPAR binding interaction can independently affect cell motility, integrin function, and gene expression (7) . In many cancers, uPAR expression is required for the invasive and metastatic phenotype (8) . uPAR overexpression increases the ability of cancer cells to penetrate a barrier of a reconstituted basement membrane. In contrast, the blockade of the uPAR by the expression of a catalytically inactive enzyme or an antisense uPAR cDNA significantly decreases the invasiveness of cancer cells. In gastric cancer, increased levels of uPA and uPAR have been clearly demonstrated to be essential for maintaining the invasive and metastatic phenotypes, and these increases are considered to be prognostically significant (9) .
The level of uPAR synthesis is increased by a diverse set of agents including the epidermal growth factor, vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, transforming growth factor, okadaic acid and phorbol ester (8, 10 ). An analysis of the genomic structure of uPAR reveals many potential targets for the regulation at both the transcriptional and posttranscriptional levels. Within its 3'-flanking region, the uPAR gene contains a single-copy AUUUA sequence that is responsible for the destabilization of various mRNAs (11) . Within its 5'-flanking region, the uPAR gene contains the putative binding sites for an activator protein-1 (AP-1), AP-2, and Sp1 but no potential TATA or CAAT boxes (12) .
An H. pylori infection has been reported to induce a number of genes in cells that are potential determinants of angiogenesis and metastasis including vascular endothelial growth factor and cyclooxygenase-2. However, it is unclear how H. pylori can activate these specific genes (13) . A myriad of intracellular signals has been suggested to mediate the effects of H. pylori, including the activation of mitogenactivated protein kinase (MAPK), the release of arachidonic acid, and the regulation of the transcription factors, AP-1 and NF-κB (14) . In addition, H. pylori stimulates the production of reactive oxygen species (ROS), which is a class of highly reactive, diffusible, and ubiquitous molecules in various cell types (15) .
In this study, it was found that H. pylori induces the expression of uPAR via ROS and the NF-κB signaling pathway, and stimulates the invasiveness of human gastric cancer AGS cells.
Materials and methods
Bacterial strains. The H. pylori strains, 26695 and J99, were obtained from the American Type Culture Collection (Manassas, VA, USA). The H. pylori strain 51 was isolated from a human biopsy obtained from a patient with a duodenal ulcer at Gyeongsang National University Hospital, Jinju, Korea (16) . The frozen H. pylori strains were thawed and grown on brucella agar containing DMCD (1 mg/ml), vancomycin (10 μg/ml), nalidixic acid (25 μg/ml) and amphotericin B (1 μg/ml) at 10% CO 2 and 37˚C. One loop of bacteria grown overnight was inoculated on a brucella agar plate enriched with DMCD (1 mg/ml) and cultured overnight under the same conditions.
Cell culture and culture conditions. Human gastric carcinoma AGS cells were obtained from the American Type Culture Collection. The cells were cultured at 37˚C in a 5% CO 2 atmosphere in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. The effect of H. pylori on uPAR expression was determined by harvesting the cells cultivated with various numbers of H. pylori and examining the expression of uPAR by Western and Northern blot analyses. The role of the specific signaling pathways in uPAR induction by H. pylori was examined by pretreating the AGS cells with 0-20 mM N-acetyl cysteine (NAC, an antioxidant, Sigma Chemical Co., St. Louis, MO, USA) and 0-20 μM BAY11-7082 (a specific inhibitor of NF-κB, Calbiochem, San Diego, CA, USA) for 1 h prior to exposure to H. pylori.
Western blot analysis. The cells were washed in phosphatebuffered saline (PBS), detached using Trypsin-EDTA buffer, and stored at -70˚C until needed. The protein was extracted with a RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) and protease inhibitors (aprotinin, leupeptin, PMSF, benzamidine, trypsin inhibitor, sodium orthovanadate). Fifty micrograms of the proteins was then separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes. The membranes were blocked in a PBS solution containing 5% nonfat dry milk, incubated with the primary antibodies in a blocking solution overnight at 4˚C, and washed three times with TPBS [Tween-20 (0.1%), PBS] at 10-min intervals. Horseradish peroxidase-conjugated secondary antibodies (Amersham Corp., Arlington Heights, IL, USA) were used to detect the immunoreactive proteins by chemiluminescence. The following antibodies were used: anti-uPAR (American Diagnostica Inc, Greenwich, CT, USA) and anti-IκB· (Santa Cruz Biotechnology Inc., Santa Cruz, CA). The total protein levels were assayed by washing the blotted membrane with a stripping solution [100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl (pH 6.7)] for 30 min at 50˚C, and the membrane was then reprobed with the anti-ß-actin mouse monoclonal antibody (Sigma Chemical Co.).
Matrigel invasion assay.
A cell invasion assay was performed using a BioCoat™ matrigel invasion chamber (BectonDickinson, Bedford, MA, USA) according to the manufacturer's protocol. Briefly, 10 5 cells in 300 μl were added to each chamber and allowed to invade the matrigel for 24 h. The noninvading cells on the upper surface of the membrane were removed from the chamber, and the invading cells on the lower surface of the membrane were stained using a QuickDiff stain kit (Becton-Dickinson). The chambers were washed twice with water and allowed to air dry. The number of invading cells was counted using phase-contrast microscopy. The effect of the anti-uPAR antibody on the H. pylori-induced cell invasion was determined by preincubating the H. pylori-treated cells with 1 μg/ml of the neutralizing antibody to uPAR for 10 min and adding them to the invasion chamber.
Measurement of intracellular H 2 O 2 . The level of intracellular H 2 O 2 was measured using 5-and 6-carboxyl-2',7'-dichlorodihydrofluorescein diacetate (DCFDA, Molecular Probes, Eugene, OR, USA) according to the procedure reported by Hwang et al (17) . Briefly, the cells were grown in serumstarved RPMI-1640 medium supplemented with 0.5% FBS for an additional 2 days. The cells were then stabilized in serum-free RPMI-1640 medium without phenol red for at least 30 min before being exposed to H. pylori for 0-90 min. The effect of NAC was assessed by pretreating the cells with NAC for 30 min and incubating them with the H 2 O 2 -sensitive fluorophore DCFDA (5 ng/ml) for 10 min. The cells were observed immediately under a laser-scanning confocal microscope. The DCF fluorescence was excited at 488 nm using an argon laser, and the emission evoked was filtered with a 515-nm-long pass filter.
Northern blot analysis. The total RNA extraction and Northern blot hybridization were performed as previously described (18) . Each cDNA probe was radiolabeled with [·-
32 P]deoxyribonucleoside triphosphate using a randompriming technique with the Rediprime labeling system (Amersham Corp.). The probed nylon membranes were exposed to radiographic film (Life Technologies, Inc., Grand Island, NY, USA).
Measurement of uPAR promoter activity.
The transcriptional regulation of uPAR was examined using the transient transfection with a uPAR promoter-luciferase reporter construct (pGL3-uPAR) (18) . The plasmid pGL3/uPARpromoter was kindly provided by Dr Y. Wang (Australian National University, Canberra, Australia). The AGS cells (5x10 5 ) were seeded and grown until they reached 60-70% confluence, and pRLTK (an internal control plasmid containing the herpes simplex thymidine kinase promoter linked to the constitutively active Renilla luciferase reporter gene) and pGL3-uPAR were then cotransfected into cells using FuGENE 6 (Boehringer Mannheim, Indianapolis, IN, USA) according to the manufacturer's protocol. pRLTK and pGL3 were cotransfected as a negative control. The cells were incubated in the transfection medium for 20 h and treated with H. pylori for 4 h. The effects of the inhibitors on the uPAR promoter activity were determined by pretreating cells with the inhibitors for 1 h prior to the addition of H. pylori. The cotransfection studies were performed in the presence or absence of 2 μg dominant-negative mutants of I-κB·, I-κBß and NF-κB-inducing kinase (NIK). The dominant-negative mutants of I-κB· and I-κBß (19) and NIK (20) were kindly provided by Dr D.W. Ballard (Vanderbilt University School of Medicine, Nashville, TN, USA) and Dr W.C. Greene (University of California, San Francisco, CA, USA), respectively. The cells were harvested using a passive lysis buffer (Dual-Luciferase Reporter assay system; Promega, Madison, WI, USA), and the luciferase activity was determined using a single sample luminometer according to the manufacturer's protocol.
Extraction of nuclear proteins. AGS cells at 80-90%
confluence were incubated overnight in the medium containing 5% FBS and then treated with various numbers of H. pylori. The cells were then re-suspended in 500 μl cold buffer A [50 mM Tris (pH 7.4), 150 mM NaCl, 0.2 mM EDTA, 3% (v/v) glycerol, and 1.5 mM MgCl 2 ]. After the cells had been allowed to swell for 5 min on ice, they were lysed with 500 μl of buffer B [identical to buffer A except containing 0.05% Nonidet P-40 (Sigma)]. The homogenate was gently layered onto an equal volume cushion of buffer C [10 mM Tris (pH 7.4), 25% (v/v) glycerol, and 1.5 mM MgCl 2 ] and centrifuged for 5 min at 200 x g. The white nuclear pellet was re-suspended in 75 μl of a cold high-salt lysis buffer [20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride]. This suspension was agitated for 30 min at 4˚C and then microcentrifuged for 15 min at 4˚C. The resulting supernatant was stored in aliquots at -80˚C.
Electrophoretic mobility shift assay (EMSA). EMSA was carried out using a Gel Shift assay system (Promega). Briefly, an oligonucleotide containing the consensus sequence of NF-κB (5'-AGT TGA GGG GAC TTT CCC AGG-3') was endlabeled with [·-32 P]adenosine triphosphate (3000 μCi/mmol; Amersham Pharmacia Biotech., Buckinghamshire, UK) using T4 polynucleotide kinase, purified in Microspin G-25 columns (Sigma) and used as the probe for EMSA. The nuclear extract proteins (6 μg) were pre-incubated with the binding buffer [10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5 mM EDTA, 1 mM MgCl 2 , 0.5 mM dithiothreitol, 4% (v/v) glycerol, and 0.05 mg/ml poly(deoxyinosine-deoxycytosine)] for 5 min and then incubated with the radiolabeled probe for 15 min at 37˚C. Each sample was electrophoresed in a 5% nondenaturing polyacrylamide gel in 0.5X Tris borate-EDTA buffer at 150 V for 4 h. The gel was then dried and subjected to autoradiography.
Transient transfection of NF-κB-reporter.
The NF-κB-reporter construct was purchased from Clontech (Palo Alto, CA). After the cells reached 80-90% confluence, they were washed with RPMI-1640 and incubated with RPMI-1640 in the absence of serum and antibiotics for 5 h. The cells were then transfected with 1 μg NF-κB-reporter containing pGL3 vector using FuGENE 6 (Boehringer Mannheim) for 24 h. After incubation, the cells were lysed and the luciferase activity was measured using a luminometer.
Chromatin immunoprecipitation. Chromatin immunoprecipitation (ChIP) was performed using the ChIP assay kit (Upstate, Lake Placid, NY) according to the manufacturer's recommendations. The cells grown on 100-mm dishes were collected and cross-linked using 1% formalin for 10 min at room temperature. The extracts were sonicated until the DNA fragments were 500-800 bp in size. The cell extracts were then subsequently incubated with 2 μg IgG or the antibody against NF-κB (Santa Cruz, sc-7151) overnight at 4˚C. The extracts were incubated with salmon sperm DNA/protein A-sepharose beads (Upstate, Charlottesville, VA) for 1 h. After extensive washing of the beads, the proteins were eluted and reversed by heating them for 4 h at 65˚C. After DNA purification, PCR was performed for 35-40 cycles. The following primers were used for the NF-κB site (284 bp): 5'-TTTTACAGCAGTGGAGAGCG-3' (sense) and 5'-TCAGGAAGGAGGCAGTTTTG-3' (antisense).
Results

Effect of H. pylori on the induction of uPAR and cell
invasiveness. AGS cells were cocultured with 3 different strains of H. pylori (26695, 51, J99), and the level of the uPAR protein in the cells was measured. As shown in Fig. 1A , all the examined H. pylori strains induced uPAR in the gastric AGS cells. It was also found that H. pylori induced uPAR in a dose-dependent manner at a bacterium/cell ratio of 1:1-200:1 (Fig. 1B) . It was suggested that uPAR is essential for the invasive phenotype of cancer cells (18) . The role of H. pylori-induced uPAR in the AGS cell invasion was examined by incubating the cells with specific antibodies to uPAR in a modified Boyden invasion chamber. As shown in Fig. 2A and B) . The level of intracellular ROS increased progressively after incubating the cells with H. pylori reaching a peak at ~15 min, with a subsequent slow decline thereafter. Pretreating the cells with 5 mM NAC, an ROS scavenger, almost completely inhibited the production of ROS ( Fig. 2A and B) . The effects of NAC on the expression of uPAR mRNA by H. pylori was next examined. As shown in Fig. 3A , the NAC pretreatment partially blocked the H. pylori-induced expression of uPAR mRNA. The effect of NAC on the transcriptional regulation of the uPAR gene was also examined. To this end, AGS cells were transiently transfected with the promoter-reporter construct (pGL3-uPAR) of the human uPAR gene and the luciferase gene. The AGS cells transfected with pGL3-uPAR showed a 4-fold increase in the promoter activity after the H. pylori treatment. When the transfected cells were pretreated with NAC before the H. pylori treatment, the induction of the uPAR promoter activity by H. pylori was inhibited in a dose-dependent manner (Fig. 3B ). In addition, exogenous H 2 O 2 alone induced uPAR expression (Fig. 3C) . 10 7 ) in BioCoat marigel invasion chambers for 24 h in the presence or absence of 50 μg/ml anti-PAR antibodies (anti-uPAR). After incubation, the invading cells on the undersurface of the chambers were counted using phase contrast light microscopy after staining with a Diff-Quick stain kit. The data represents the means ± SD from triplicate measurements. Fig. 4A , the H. pylori treatment caused a remarkable increase in the amount of NF-κB that could form complexes with the radiolabeled oligonucleotide probes in EMSA. The activation of NF-κB is usually associated with the induction of I-κB phosphorylation, which is followed by its degradation by proteasome and NF-κB nuclear translocation (21) . Therefore, the change in the amount of I-κB in AGS cells was determined by Western blotting using an antibody to I-κB. The result showed that the AGS cells treated with H. pylori showed a loss of the I-κB protein in a dose-dependent manner (Fig. 4B) . The extent to which H. pylori modulated NF-κB-dependent transcription activity was next evaluated using NF-κB-reporter (luciferase). As shown in Fig. 4C , the H. pylori treatment caused increases in the NF-κB-dependent transcription activity in a dose-dependent manner.
Activation of NF-κB by H. pylori. H. pylori was further examined to determine if it could activate the transcription factor NF-κB in gastric AGS cells. As shown in
Involvement of NF-κB in uPAR induction by H. pylori.
The role of the transcription factor NF-κB in the induction of uPAR by H. pylori was examined by pretreating the AGS cells with 0-20 μM BAY11-7082 (a specific inhibitor of NF-κB) before the H. pylori treatment. BAY11-7082 blocked the H. pyloriinduced uPAR mRNA expression and uPAR promoter activity in a dose-dependent manner (Fig. 5A and B) . The importance of NF-κB in the induction of uPAR by H. pylori was confirmed by transfecting the AGS cells with the uPAR promoter-reporter in which the NF-κB site was mutated. As shown in Fig. 5B , a mutation of the NF-κB binding site significantly reduced the H. pylori-induced activation of the uPAR promoter. The effects of the dominant-negative mutant forms of I-κB and NIK on the uPAR promoter were investigated. The results showed that inhibition of the NF-κB signals significantly inhibited the H. pylori-induced uPAR promoter activity (Fig. 5C) . In order to further confirm that transcription factor NF-κB is essential in H. pylori-induced uPAR, the binding of NF-κB on the uPAR promoter was examined by chromatin immunoprecipitation. As shown in Fig. 5D , the level of binding of endogenous NF-κB to the NF-κB binding site on the uPAR promoter sequences was increased after the H. pylori treatment. This suggests the involvement of NF-κB in the uPAR induction by H. pylori.
Activation of NF-κB by ROS.
Considering that H. pylori can generate reactive oxygen species and that NF-κB is a redoxsensitive transcription factor, it is natural to speculate on the role of ROS with regard to NF-κB activation in H. pylorimediated uPAR induction. The AGS cells were pretreated with NAC before the H. pylori treatment and the level of NF-κB-DNA binding was examined in EMSA. As shown in Fig. 6A , NAC inhibited the H. pylori-induced NF-κB-DNA binding. The effects of NAC on the NF-κB-dependent transcription activity were next examined. As shown in Fig. 6B , the NAC pretreatment blocked the H. pylori-induced NF-κB-dependent transcription activity in a dose-dependent manner. In addition, the exogenous H 2 O 2 alone induced the NF-κB-DNA binding (Fig. 6C) . These results suggested that the intracellular H 2 O 2 produced by H. pylori contributed to the activation of NF-κB in gastric AGS cells.
Effects of NAC and BAY11-7082 on the H. pylori-induced cell invasiveness.
This study showed that H. pylori induced uPAR through ROS and NF-κB, and the uPAR induced by H. pylori plays an important role in the invasiveness of gastric cancer cells (Fig. 1) . The effects of NAC and BAY11-7082 on the cell invasiveness were investigated to determine if the ROS and NF-κB are required for this process. As shown in Fig. 7 , both NAC and BAY11-7082 inhibited the H. pyloriinduced cell invasiveness in a dose-dependent manner.
Discussion
H. pylori is a bacterium that lives in the stomach and duodenum. Although the pathogenesis of gastroduodenal diseases caused by this bacterium is not well understood, some immunologic mechanisms are believed to be involved in gastric inflammation. Recently, considerable effort has been directed at defining the role of H. pylori in the development and progression of gastric cancer as stimulated by the following observations: i) epidemiologic studies have indicated that an infection with H. pylori is a risk factor for gastric carcinoma (22, 23) , ii) long-term studies suggest that the association between an H. pylori infection and gastric cancer ranks with that between smoking and lung cancer (24), iii) H. pylori induces various genes associated with gastric cancer angiogenesis and metastasis including vascular endothelial growth factor (25), IL-8 (26) and MMPs (26) and iv) Mongolian gerbils with H. pylori inoculated into the stomach develop chronic gastritis, intestinal metaplasia, and adenocarcinoma (27) . It was previously reported that H. pylori induced uPAR expression and stimulated the cell invasiveness in human gastric cancer AGS cells, suggesting that the overexpression of uPAR induced by H. pylori is involved in the increased cell invasiveness (18) . However, the precise mechanisms for how H. pylori upregulates the uPAR are unknown. Recently, Choi et al (28) demonstrated that the overexpression of uPAR in human gastric carcinomas correlates with their invasiveness and tumorigenicity. The plasminogen activation system and MMPs play key roles in the degradation of the basement membrane and extracellular matrix in tissue remodeling, cell invasion, and angiogenesis. uPA, a serine protease, has the ability to convert a plasminogen to active plasmin and activates the MMPs and growth factors (6). Gooz et al (26) reported that the levels of MMPs and their inhibitors secreted by AGS gastric carcinoma cells were increased by an H. pylori infection.
The results showed that H. pylori induced the production of ROS in AGS cells. The increase in the level of ROS was detectable within 10 min after exposing the cells to H. pylori. The production of ROS precedes the induction of uPAR expression, and this upregulation is attenuated by NAC, a ROS scavenger. In addition, exogenous ROS alone induced the expression and promoter activity of uPAR. These results indicate a role of ROS in the activation of the uPAR gene by H. pylori. The molecular mechanism for ROS production by H. pylori remains unclear. Bagchi et al (29) reported that human gastric cells incubated with an 87-kDa cytotoxin produced from H. pylori enhanced the production of ROS, as determined by the reduction of cytochrome c and the level of hydroxyl radicals and DNA damage. Teshima et al (30) reported that gastric epithelial cells contain phagocyte NADPH oxidase components (gp91-, p22-, p67-, p47-, and p40-phoxes), and that these cells produce ROS through the activation of nonphagocytic NADPH oxidase in response to H. pylori. In addition to the gastric mucosa, it was suggested that the sources of ROS production are probably the host neutrophils, which are activated by the soluble factors of H. pylori. Davies et al (31) reported elevated levels of ROS in duodenal biopsies from patients with active duodenal ulcers. The chemiluminescence was higher in H. pyloripositive tissue than in negative tissue when samples were grouped according to the equivalent macroscopic or microscopic damage. This difference was in part accounted for by a higher level of neutrophil infiltration in the H. pyloripositive mucosa. However, when the biopsy specimens with equivalent neutrophil infiltration were compared directly, the H. pylori-positive specimens gave greater chemiluminescence than the negative tissue specimens.
The results suggest that the ROS produced by H. pylori can stimulate the cell invasiveness by upregulating uPAR expression in gastric AGS cells. Several laboratories have reported convincing evidence that antioxidants offer protection against tumor invasion and metastasis using both in vivo and in vitro studies. Asc-2-O-phosphate-6-O-palmitate, a lipophilic and autooxidation-resistant derivative of ascorbic acid was shown to inhibit an invasion by fibrosarcoma cells using its potent antioxidant activity (32) . In addition, the administration of Cu-Zn superoxide dismutase, an enzyme that scavenges superoxide, successfully reduced the lung Figure 6 . Effect of ROS produced by H. pylori on the activation of NF-κB. (A) The AGS cells, after being pretreated with 0-20 mM NAC, were incubated with H. pylori 51 for 4 h at a bacterium/cell ratio of 100:1. After incubation, the nuclear extracts from the cells were analyzed by EMSA for activated NF-κB using a radiolabeled oligonuclotide probe. (B) The AGS cells were transiently transfected with the pNF-κB-Luc-reporter construct. The transfected cells were pretreated with 0-20 mM NAC, and incubated with H. pylori 51 for 4 h at a bacterium/cell ratio of 100:1. After incubation, the cells were lysed and the luciferase activity was determined using a luminometer. The data represents the means ± SD from triplicate measurements. (C) The AGS cells were incubated with 0-100 μM H 2 O 2 for 4 h, and the level of activated NF-κB in the nuclear extracts from the cells were analyzed by EMSA. metastasis of mouse MethA sarcoma and Lewis lung carcinoma cell lines (33) . Zhang et al (34) reported that the exogenous ROS produced by the hypoxanthine-xanthine oxidase system increased the invasion of mesothelial cells.
The following observations suggest that NF-κB is also involved in the signaling pathway for the induction of uPAR by H. pylori in AGS cells: i) the H. pylori treatment increased the amount of NF-κB, which could form a complex with the radiolabeled oligonucleotide probe in EMSA; ii) AGS cells treated with H. pylori showed a loss of the I-κB· protein; iii) the H. pylori treatment also resulted in an increase in the NF-κB-dependent transcriptional activity, as revealed by the Luc reporter construct assay; iv) the induction of the uPAR promoter activity by H. pylori was inhibited by inhibiting the NF-κB signals; and v) the level of binding of endogenous NF-κB to the NF-κB binding site on the uPAR promoter sequences was increased after the H. pylori treatment, as determined by chromatin immunoprecipitation.
Overall, these results suggest that ROS are involved in the signaling pathway for NF-κB activation by H. pylori in gastric AGS cells. As shown in Fig. 6 , NAC inhibited the NF-κB-DNA binding and NF-κB-dependent transcription activity induced by H. pylori. Furthermore, exogenous H 2 O 2 alone induced NF-κB-DNA binding. The mechanism by which ROS stimulates the NF-κB pathway is unclear. Li and Engelhardt (35) reported that the recruitment of NIK to TRAF6 is mechanistically important for the ROS induction of NF-κB activation. Storz and Toker (36) showed that protein kinase D (PKD) is essential for ROS-induced NF-κB activation by inducing the tyrosine phosphorylation of IKK. Src and Abl mediate PKD activation in response to H 2 O 2 stimulation, via the phosphorylation of Tyr463 in the PKD pleckstrin homology domain. Similarly, Fan et al (37) reported that ROS controlled NF-κB activation through the cSrc-dependent tyrosine phosphorylation of I-κB. However, ROS-induced NF-κB activation is strongly dependent on the cell type.
This study reports that the ROS produced by H. pylori induces the activity of NF-κB, which subsequently upregulates uPAR expression resulting in increased cell invasiveness in gastric cancer cells. Understanding the mechanism by which uPAR expression is regulated by H. pylori may lead to the development of new strategies for treating gastric carcinomas. Therefore, further study is needed to elucidate the detailed regulatory mechanism.
